BALYASNY ASSET MANAGEMENT LLC
Q2 2020 13F-HR Holdings
Net value change ($000)
+3,093,177
(36.7%)
New positions
434
Sold out positions
502
Turnover %
76.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SCHW | 86,272 | NEW |
| PYPL | 79,774 | 889.7% |
| ABT | 75,843 | NEW |
| FISV | 73,497 | 197.4% |
| BABA | 72,088 | 1110.6% |
| JPM | 71,714 | 117.0% |
| TGT | 70,914 | NEW |
| HD | 69,702 | NEW |
| ADBE | 66,950 | NEW |
| CPAY | 65,486 | 1377.2% |
Top Reduces (Value $000, Stocks/ETFs)
| Allergan plc | -92,368 | -100.0% |
| JCI | -76,870 | -100.0% |
| TD AMERITRADE HOLDING CORP | -67,773 | -100.0% |
| INTC | -67,368 | -100.0% |
| BSX | -65,928 | -92.7% |
| LOW | -65,032 | -75.6% |
| DG | -62,683 | -90.2% |
| CHTR | -58,940 | -100.0% |
| KR | -57,252 | -100.0% |
| TMUS | -53,469 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
1,971,457
(17.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|